Cardiomyopathy associated with neurologic disorders and mitochondrial phenotype.
Cardiomyopathy and neuromuscular abnormalities may simultaneously coexist and present with defects in mitochondrial DNA and bioenergetic function. We sought to evaluate the relationship between clinical and mitochondrial phenotypes in 28 young patients with both cardiomyopathy and neurologic disorders including seizures, dystonia, ophthalmoplegia, Kearns-Sayre syndrome, Leigh disease, and Friedreich's ataxia. All tissues examined displayed marked defects in respiratory complex activities. Five patients had abundant large-scale mitochondrial DNA deletions and one patient displayed a pathogenic point mutation previously reported with mitochondrial cytopathy. In this cohort, patients with hypertrophic cardiomyopathy displayed a higher incidence of complex I defects, fewer DNA deletions and mitochondrial structural abnormalities and were less often associated with developmental delay phenotype compared with patients with dilated cardiomyopathy. Although structural abnormalities are present in a subset of patients, evaluation of respiratory enzyme activity appears to be most informative whether tissues examined were derived from heart or skeletal muscle. Defects in mitochondrial DNA and bioenergetics are frequently present in children with cardiomyopathy presenting with a variety of neurologic abnormalities and are amenable to biochemical and molecular analysis.
Marín-García
José
J
Molecular Cardiology and Neuromuscular Institute, Highland Park, NJ 08904, USA. tmci@att.net
Goldenthal
Michael J
MJ
Filiano
James J
JJ
D000293:Adolescent; D009202:Cardiomyopathies / Q000235:genetics* / Q000473:pathology* / Q000503:physiopathology; D002648:Child; D002675:Child, Preschool; D004272:DNA, Mitochondrial; D004421:Dystonia / Q000473:pathology; D042967:Electron Transport Complex I; D005260:Female; D005621:Friedreich Ataxia / Q000473:pathology; D017353:Gene Deletion; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007625:Kearns-Sayre Syndrome / Q000473:pathology; D007888:Leigh Disease / Q000473:pathology; D008297:Male; D008928:Mitochondria / Q000235:genetics* / Q000473:pathology*; D017240:Mitochondrial Myopathies / Q000235:genetics / Q000473:pathology; D018482:Muscle, Skeletal / Q000473:pathology; D009154:Mutation; D009206:Myocardium / Q000473:pathology; D009247:NADH, NADPH Oxidoreductases / Q000378:metabolism; D009468:Neuromuscular Diseases / Q000473:pathology; D009886:Ophthalmoplegia / Q000473:pathology; D010641:Phenotype; D012640:Seizures / Q000473:pathology
D004272:DNA, Mitochondrial; D009247:NADH, NADPH Oxidoreductases; D042967:Electron Transport Complex I